Lazard Asset Management LLC Repligen Corp Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 12 shares of RGEN stock, worth $1,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 18 33.33%

Holding current value

$1,858

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $718 - $1,004	-6 Reduced 33.33%	12 $1,000
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $22,080 - $33,662	-184 Reduced 91.09%	18 $2,000
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $23,226 - $28,345	136 Added 206.06%	202 $36,000
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $228 - $370	-2 Reduced 2.94%	66 $11,000
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $416 - $529	3 Added 4.62%	68 $10,000
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $59,520 - $77,533	-430 Reduced 86.87%	65 $9,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $41,804 - $53,685	-271 Reduced 35.38%	495 $83,000
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $16,566 - $22,497	102 Added 15.36%	766 $129,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $11,550 - $18,447	72 Added 12.16%	664 $124,000
Q2 2022 Aug 09, 2022	BUY	$140.68 - $188.02 $18,569 - $24,818	132 Added 28.7%	592 $96,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $763,073 - $1.22 Million	-4,734 Reduced 91.14%	460 $86,000
Q4 2021 Feb 09, 2022	SELL	$247.59 - $304.47 $1.16 Million - $1.43 Million	-4,690 Reduced 47.45%	5,194 $1.38 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.5 Million - $2.5 Million	-7,707 Reduced 43.81%	9,884 $2.86 Million
Q2 2021 Aug 12, 2021	BUY	$165.87 - $220.95 $48,268 - $64,296	291 Added 1.68%	17,591 $3.51 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $3.12 Million - $3.91 Million	17,300 New	17,300 $3.36 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Repligen Corp Transaction History